The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

After a delayed approval, treosulfan’s manufacturer is hopeful the alkylating agent will become the new gold standard in the United States.

The FDA approves Spravato, a nasal spray derived from Ketamine, to help some people treat depression. Dr. Bill Hartman from UW Health shares more.

Agency cites contamination at Massachusetts plant where company makes ingredients used to produce various medicines ...

Over 35 years after the first study linking Red 3 to thyroid cancer in rats was published, the US is beginning to wean it out of foods and drugs.

The U.S. Food and Drug Administration has issued a recall on a popular skin moisturizer that's available nationwide. Do you have this product?

The Food and Drug Administration announced last week that it will revoke authorization for FD&C Red No. 3 in food and ingested drugs under the Delaney Clause of the Federal Food, Drug, and Cosmetic ...

Following the Trump administration's DEI ban, the FDA's move to scrub webpages has ensnared many pages focused on ensuring diversity in drug trials.

The Trump administration’s freeze on communications from U.S. health agencies is leading to another disruption: the abrupt cancellation of scientific meetings. The move covers a swath of health ...

Over the years, an increasing number of studies have linked formaldehyde to cancers that are especially prevalent among Black ...

The FDA has accepted a BLA for treatment with RP1 in combination with Opdivo for patients with advanced melanoma who have progressed on prior therapy.

After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...